REMINDER: Revelation Biosciences to Host Fireside Chat at 38th Annual Roth Conference
Revelation Biosciences (NASDAQ:REVB) will participate in a fireside chat at the 38th Annual Roth Conference on March 24, 2026 at 2:00 p.m. PT in Dana Point, CA.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Revelation Biosciences (NASDAQ:REVB) will participate in a fireside chat at the 38th Annual Roth Conference on March 24, 2026 at 2:00 p.m. PT in Dana Point, CA.
The event will be webcast live and later archived in the Investors section of Revelation Biosciences' website at www.RevBiosciences.com.
Details
News Market Reaction – REVB
On Mar 24, the day this news came out, REVB closed 8.20% below the previous close.
Data tracked by StockTitan Argus for the Mar 24 session.
Key Figures
- Conference date
- March 24, 2026
- Date of REVB fireside chat at 38th Annual Roth Conference
- Session time
- 2:00 p.m. PT
- Scheduled start time of the fireside chat
- Conference edition
- 38th Annual Roth Conference
- Event where Revelation Biosciences will host a fireside chat
Historical Context
-
Announcement of Roth Conference attendance and fireside chat scheduling.
-
Reported FY 2025 results, cash of $10.7M, Gemini progress and runway.
-
1-for-4 reverse split to address Nasdaq minimum bid requirement.
-
Reduced-price warrant exercise and issuance of new Class J warrants.
-
FDA agreement on single adaptive Phase 2/3 Gemini AKI study of ~300 patients.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, CA / ACCESS Newswire / March 24, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company focused on rebalancing inflammation to optimize health, today announced a reminder of its participation in a fireside chat on Tuesday, March 24, 2026, at 2:00 p.m. PT, as part of the 38th Annual Roth Conference, in Dana Point, CA.
The fireside chat will be webcast live here and available on our Investors section of the Revelation Biosciences website, www.RevBiosciences.com, after the meeting.
About Revelation Biosciences, Inc.
Revelation Biosciences, Inc. is a clinical-stage life sciences company focused on rebalancing inflammation using its proprietary formulation, Gemini. Revelation has multiple ongoing programs to evaluate Gemini as a treatment for acute kidney injury, a treatment of chronic kidney disease, prevention of post-surgical infection, and a treatment to reduce hyperinflammation and infection associated with severe burn.
For more information, please visit www.RevBiosciences.com.
Company Contacts
Mike Porter
Investor Relations
Porter LeVay & Rose Inc.
Email: mike@plrinvest.com
Chester Zygmont, III
Chief Financial Officer
Revelation Biosciences Inc.
Email: czygmont@revbiosciences.com
SOURCE: Revelation Biosciences Inc.
View the original press release on ACCESS Newswire
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.